Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Cytochrome c pseudogene 41 (HCP41/CYCSP41) is a truncated, non-functional sequence in the human genome, classified as a pseudogene. It is one of 49 cytochrome c-derived pseudogenes identified via computational analysis and annotated by their chromosomal position[1][2]. These pseudogenes typically lack the necessary introns found in the functional gene, often feature frameshifts, premature stop codons, or truncations, which prevent expression of a full-length or functional protein. HCP41 is specifically noted as being truncated at one end[1][2]. There is no evidence that HCP41 is expressed or translated, and it does not contribute to biological functions or disease processes. Pseudogenes such as HCP41 are considered evolutionary remnants and are not molecular targets for therapy or diagnosis[1][2].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Cytochrome c pseudogene 41 (HCP41).